Positron-emission tomographic imaging of cancer: Glucose metabolism and beyond

被引:38
作者
Mankoff, DA
Bellon, JR
机构
[1] Univ Washington, Med Ctr, Div Nucl Med, Seattle, WA 98195 USA
[2] Univ Washington, Dept Radiat Oncol, Seattle, WA 98195 USA
关键词
D O I
10.1053/srao.2001.18100
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Positron emission tomography (PET) has become an important diagnostic tool in oncology. We briefly review the physics of PET, instrumentation for imaging, and approaches to radiopharmaceutical production. The principles underlying the use of [18F]-fluorodeoxyglucose (FDG) are described, and the clinical experience with FDG pertinent to radiation oncology is reviewed. Finally, preliminary studies using PET tracers with greater specificity than FDG for tumor imaging are discussed. Emphasis is placed on underlying principles and those aspects of oncologic PET most applicable to radiation oncology. © 2001 by W.B. Saunders Company.
引用
收藏
页码:16 / 27
页数:12
相关论文
共 102 条
[1]   Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer [J].
Adams, S ;
Baum, RP ;
Stuckensen, T ;
Bitter, K ;
Hör, G .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1998, 25 (09) :1255-1260
[2]   Axillary lymph node metastases: Screening with [F-18]2-deoxy-2-fluoro-D-glucose (FDG) PET [J].
Adler, LP ;
Faulhaber, PF ;
Schnur, KC ;
AlKasi, NL ;
Shenk, RR .
RADIOLOGY, 1997, 203 (02) :323-327
[3]  
Ahuja V, 1998, CANCER, V83, P918, DOI 10.1002/(SICI)1097-0142(19980901)83:5<918::AID-CNCR17>3.3.CO
[4]  
2-#
[5]  
Aloj L, 1999, CANCER RES, V59, P4709
[6]   Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)fluoro-2-deoxy-D-glucose [J].
Avril, N ;
Dose, J ;
Janicke, F ;
Ziegler, S ;
Romer, W ;
Weber, W ;
Herz, M ;
Nathrath, W ;
Graeff, H ;
Schwaiger, M .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (17) :1204-1209
[7]  
Barker FG, 1997, CANCER, V79, P115, DOI 10.1002/(SICI)1097-0142(19970101)79:1<115::AID-CNCR17>3.3.CO
[8]  
2-#
[9]  
Bassa P, 1996, J NUCL MED, V37, P931
[10]   F-18 fluorodeoxyglucose positron emission tomography in the non-invasive staging of non-small cell lung cancer [J].
Berlangieri, SU ;
Scott, AM ;
Knight, SR ;
Fitt, GJ ;
Hennessy, OF ;
Tochon-Danguy, HJ ;
Clarke, CP ;
McKay, WJ .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 1999, 16 :S25-S30